Incyte to Present at Upcoming Investor Conferences

Audio By Carbonatix

WILMINGTON, Del.--(BUSINESS WIRE)--Feb 17, 2026--

Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of March:

• TD Cowen 46 th Annual Health Care Conference on Monday, March 2, 2026 at 10:30 am (EST)
  
  
• Leerink Partners 2026 Global Healthcare Conference on Tuesday, March 10, 2026 at 9:20 am (EDT) and
  
  
• Barclays 28 th Annual Global Healthcare Conference on Wednesday, March 11, 2026 at 8:30 am (EDT)

The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.

About Incyte

A global biopharmaceutical company on a mission to Solve On., Incyte follows the science to find solutions for patients with unmet medical needs. Through the discovery, development and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Oncology and Inflammation & Autoimmunity. Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe and Asia.

For additional information on Incyte, please visit Incyte.com or follow us on social media: LinkedIn, X, Instagram, Facebook, YouTube.

View source version on businesswire.com:https://www.businesswire.com/news/home/20260217945807/en/

CONTACT: Incyte Contacts

Media

[email protected]

[email protected]

KEYWORD: DELAWARE UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: BIOTECHNOLOGY OTHER HEALTH HEALTH PHARMACEUTICAL ONCOLOGY

SOURCE: Incyte

Copyright Business Wire 2026.

PUB: 02/17/2026 08:00 AM/DISC: 02/17/2026 08:00 AM

http://www.businesswire.com/news/home/20260217945807/en